Skip to main content

Decibel Therapeutics, Inc.

DBTXDelisted Sep 25, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001656536

Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Decibel Therapeutics, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of DBTX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders4039−1
Shares17.9M17.5M−458.1K (−2.6%)
Value$62.1M$35.8M−$26.2M (−42.3%)

New holders (4)

Institutions that held Decibel Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to DBTX in Q4 2022
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.90,000$184.5K0.00%
Ergoteles LLC23,480$48.1K0.00%
Clear Street Markets LLC1,500$3.00K0.00%
Cubist Systematic Strategies, LLC802$1.64K0.00%

Sold out (5)

Institutions that held Decibel Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of DBTX in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
EAM Investors, LLC236,966$820.0K
ExodusPoint Capital Management, LP213,107$737.0K
UBS Oconnor LLC157,745$546.0K
Citigroup Inc291$1.00K
China Universal Asset Management Co., Ltd.233$1.00K